Renin-angiotensin-aldosterone system gene polymorphisms in coronary artery bypass graft surgery patients

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 2, 2010, Pages 136-145

  Ragia, Georgia ^a   Nikolaidis, Eleftherios ^b   Tavridou, Anna ^a   Arvanitidis, Kostas I ^a   Kanoni, Stavroula ^c   Dedoussis, George V ^c   Bougioukas, George ^b   Manolopoulos, Vangelis G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Academic General Hospital Alexandroupolis   (Greece)

^c HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Angiotensin II type 1 receptor (AT1 receptor); Angiotensin converting enzyme (ACE); Angiotensinogen (AGT); Coronary artery bypass graft surgery; Coronary artery disease; Gene score; Genetic polymorphism; Hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM; SURGICAL PATIENT;

AGED; AGED, 80 AND OVER; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 77953210630     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320310361742     Document Type: Article

References (50)

1. Brewster UC, Setaro JF, Perazella MA The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 2003; 326: 15-24.
2. Hammoud RA, Vaccari CS, Nagamia SH, Khan BV Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vasc Health Risk Manag 2007; 3: 937-945.
3. Gomez RA Molecular biology of components of the renin-angiotensin system during development. Pediatr Nephrol 1990; 4: 421-423.
4. Jeunemaitre X., Soubrier F., Kotelevtsev YV et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
5. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
6. Bonnardeaux A., Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63-69.
7. Soubrier F., Corvol P. Clinical implications of the molecular biology of the renin-angiotensin system. Eur Heart J 1990; 11: 3-10.
8. Buraczynska M., Pijanowski Z., Spasiewicz D. et al. Renin-angiotensin system gene polymorphisms: assesssment of the risk of coronary heart disease. Kardiol Pol 2003; 58: 1-9.
9. Rodriguez-Perez JC, Rodriguez-Esparragon F., Hernandez-Perera O. et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. J Am Coll Cardiol 2001; 37: 1536-1542.
10. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R., Jensen G., Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41: 1202-1211.
11. Berdeli A., Sekuri C., Sirri Cam F. et al. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 2005; 351: 87-94.
12. Agrawal S., Singh VP, Tewari S. et al. Angiotensin-converting enzyme gene polymorphism in coronary artery disease in north India. Indian Heart J 2004; 56: 44-46.
13. Agerholm-Larsen B., Tybjaerg-Hansen A., Frikke-Schmidt R., Gronholdt ML, Jensen G., Nordestgaard BG ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med 1997; 127: 346-355.
14. Alvarez R., Reguero JR, Batalla A. et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998; 40: 375-379.
15. Andrikopoulos GK, Richter DJ, Needham EW et al. The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004; 11: 477-483.
16. Fukazawa R., Sonobe T., Hamamoto K. et al. Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 2004; 56: 597-601.
17. Tsai CT, Hwang JJ, Ritchie MD et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007; 195: 172-180.
18. Fatini C., Abbate R., Pepe G. et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J 2000; 21: 633-638.
19. Humphries SE, Cooper JA, Talmud PJ, Miller GJ Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin Chem 2007; 53: 8-16.
20. Kanoni S., Dedoussis GV Design and descriptive characteristics of the GHRAS: the Greek Health Randomized Aging Study. Med Sci Monit 2008; 14: 204-212.
21. Eagle KA, Guyton RA, Davidoff R. et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 2004; 44: 213-310.
22. Mansia G., De Backer G., Dominiczak A. et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16: 135-232.
23. Iordanidoi M., Tavridou A., Vasiliadis MV et al. The-795C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogenet Genomics 2008; 18: 153-159.
24. Losito A., Kalidas K., Santoni S., Ceccarelli L., Jeffery S. Polymorphism of renin-angiotensin system genes in dialysis patients-association with cerebrovascular disease. Nephrol Dial Transplant 2002; 17: 2184-2188.
25. Lindpaintner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
26. Shanmugam V., Sell KW, Saha BK Mistyping ACE heterozygotes. PCR Methods Appl 1993; 3: 120-121.
27. Solari V., Puri P. Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension. J Pediatr Surg 2004; 39: 302-306.
28. Yiannakouris N., Trichopoulou A., Benetou V., Psaltopoulou T., Ordovas JM, Trichopoulos D. A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort. Eur J Epidemiol 2006; 21: 859-867.
29. Renner W., Nauck M., Winkelmann BR et al. Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med 2005; 83: 235-239.
30. Sethi AA, Nordestgaard BG, Agerholm-Larsen B., Frandsen E., Jensen G., Tybjaerg-Hansen A. Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study. Hypertension 2001; 37: 875-881.
31. Inoue I., Nakajima T., Williams CS et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-1797.
32. Jeunemaitre X., Inoue I., Williams C. et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-1460.
33. Nair KG, Shalia KK, Ashavaid TF, Dalal JJ Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003; 17: 141-146.
34. Lin J., Hu FB, Qi L., Curhan GC Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus. BMC Nephrol 2009; 10: 9-16.
35. Gardemann A., Stricker J., Humme J. et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis 1999; 145: 309-314.
36. Zhu X., Yan D., Cooper RS et al. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 2003; 13: 173-181.
37. Cambien F., Poirier O., Lecerf L. et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
38. Ortlepp JR, Vosberg HP, Reith S. et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart 2002; 87: 270-275.
39. Terzic R., Letonja M., Terzic I., Sehic A., Meric M., Teran N. Insertion/deletion polymorphism of angiotensin-converting enzyme gene-risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina). Coll Antropol 2003; 27: 537-540.
40. Oei HH, Sayed-Tabatabaei FA, Hofman A., Oudkerk M., van Duijn CM, Witteman JC The association between angiotensin-converting enzyme gene polymorphism and coronary calcification. The Rotterdam Coronary Calcification Study. Atherosclerosis 2005; 182: 169-173. (Pubitemid 41188383)
41. Arca M., Pannitteri G., Campagna F. et al. Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients. Eur J Clin Invest 1998; 28: 485-490. (Pubitemid 28326414)
42. Ferrieres J., Ruidavets JB, Fauvel J. et al. Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease. Atherosclerosis 1999; 142: 211-216.
43. Tiret L., Blanc H., Ruidavets JB et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet dĝ€™ Etude des Genes de lĝ€™Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 1998; 16: 37-44.
44. Canavy I., Henry M., Morange PE et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000; 83: 212-216.
45. Araujo MA, Menezes BS, Lourenco C., Cordeiro ER, Gatti RR, Goulart LR The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction. Arq Bras Cardiol 2004; 83: 409-413.
46. Kee F., Morrison C., Poirier O. et al. Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women. Eur J Clin Invest 2000; 30: 1076-1082.
47. Vassilikioti S., Doumas M., Douma S. et al. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens 1996; 9: 700-702.
48. Tsezou A., Karayannis G., Giannatou E., Papanikolaou V., Triposkiadis F. Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population. J Renin Angiotensin Aldosterone Syst 2008; 9: 202-207.
49. Humphries SE, Yiannakouris N., Talmud PJ Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative? Curr Opin Lipidol 2008; 19: 128-132.
50. Kathiresan S., Melander O., Anevski D. et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008; 358: 1240-1249.